12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights 1 hour ago
Movers
Gainers PepGen (NASDAQ:PEPG) stock rose 126.6% to $5.42 during Tuesday's regular session. The company's market cap stands at $165.5 million. The company's, Q3 earnings came out today. Nano X Imaging
Gainers
- PepGen (NASDAQ:PEPG) stock rose 126.6% to $5.42 during Tuesday's regular session. The company's market cap stands at $165.5 million. The company's, Q3 earnings came out today.
- Nano X Imaging (NASDAQ:NNOX) stock increased by 35.31% to $0.32. The company's market cap stands at $18.3 million.
- Longeveron (NASDAQ:LGVN) stock increased by 30.34% to $2.62. The market value of their outstanding shares is at $6.4 million.
- Estrella Immunopharma (NASDAQ:ESLA) shares rose 25.25% to $0.64. The company's market cap stands at $22.3 million.
- Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock moved upwards by 24.31% to $0.18.
- Humacyte (NASDAQ:HUMA) stock rose 21.94% to $0.56. The market value of their outstanding shares is at $126.4 million. As per the news, the Q3 earnings report came out today.
Losers
- Karyopharm Therapeutics (NASDAQ:KPTI) shares decreased by 42.5% to $0.02 during Tuesday's regular session.
- Tessera Defense (AMEX:HLSQ) stock fell 37.44% to $0.07. The market value of their outstanding shares is at $2.3 million.
- Exagen (NASDAQ:XGN) shares decreased by 28.6% to $5.07. The company's market cap stands at $171.5 million. The company's, Q3 earnings came out today.
- Cosmos Health (NASDAQ:COSM) stock declined by 26.59% to $0.2. The company's market cap stands at $26.9 million.
- P3 Health Partners (NASDAQ:PIII) stock fell 24.95% to $3.19. The market value of their outstanding shares is at $16.6 million. The company's, Q3 earnings came out yesterday.
- Coherus Oncology (NASDAQ:CHRS) stock declined by 22.44% to $0.63. The market value of their outstanding shares is at $126.3 million. As per the news, the Q3 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
